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Abstract
Purpose/Objectives—To examine partner involvement in treatment decision making for 
localized prostate cancer, congruence between partner involvement and patient preference, reasons 
for partner noninvolvement, and partner satisfaction with patient treatment.
Design—Cross-sectional exploratory study.
Setting—100 counties in North Carolina.
Sample—281 partners of men with newly diagnosed localized prostate cancer.
Methods—Participants completed a phone survey. Logistic regression analyses were used.
Main Research Variables—Partners’ involvement in treatment decision making, partner 
satisfaction with treatment, activities of partner involvement, and reasons for noninvolvement.
Findings—Two hundred twenty-eight partners (81%) related to decision making, 205 (73%) 
were very satisfied with the treatment the patients received, and partner involvement was 
congruent with patient preference in 242 partners (86%). Partners reported several reasons for 
noninvolvement: agreeing with whatever the patient decides, trusting the doctor’s decisions, 
believing that the patient should make the decision, respecting the patient’s decision, and being 
concerned with the impact on their relationship if they chose the wrong treatment.
Conclusions—Most partners engaged in multiple activities during treatment decision making 
for localized prostate cancer and were satisfied with the patient’s treatment. Partner involvement 
was mostly congruent with patient preference.
Implications for Nursing—Partners’ active involvement in treatment decision making for 
localized prostate cancer (e.g., being involved in patients’ conversations with doctors) should be 
encouraged and facilitated for those who prefer this type of decision making.
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Prostate cancer is the most frequently diagnosed cancer among men in the United States 
(American Cancer Society, 2015; National Cancer Institute, 2014), with the vast majority 
(81%) of the diagnosed cases being localized and potentially curable (National Cancer 
Institute, 2014). Treatment decision making is a taxing process for patients with localized 
prostate cancer because of a large number of available treatment options (e.g., active 
surveillance, different types of prostatectomy, various forms of radiation with or without 
hormonal therapy) (National Comprehensive Cancer Network, 2015). For patients in a 
sexual relationship, healthcare providers treating prostate cancer commonly recommend that 
the patient’s partner be involved in treatment decision making (Boehmer & Clark, 2001). 
However, existing research often describes treatment decision making as a dyadic process 
between the patient and healthcare providers (Zeliadt et al., 2006), with little emphasis on 
partner involvement. Most descriptive (Berry et al., 2006; Diefenbach & Mohamed, 2007; 
Shaw, Scott, & Ferrante, 2013) and intervention studies (Berry et al., 2013; Lin, Aaronson, 
Knight, Carroll, & Dudley, 2009) about treatment decision making for prostate cancer have 
focused on the patients’ concerns and satisfaction with treatment decision making. However, 
partners play an important role in how well patients with prostate cancer manage their illness 
(Ervik, Nordøy, & Asplund, 2013; Wootten et al., 2014; Wu, Mohamed, Winkel, & 
Diefenbach, 2013). Partners provide informational support (e.g., gathering information, 
helping patients understand information) and emotional support (e.g., comfort, 
companionship) (Laidsaar-Powell et al., 2013; Sinfield, Baker, Agarwal, & Tarrant, 2008; 
Srirangam et al., 2003; Street et al., 2010). Previous research found that some partners were 
completely excluded from the treatment decision-making process for prostate cancer, and 
other couples had a joint decision-making style in which the partner discussed treatment 
issues with the patient (Boehmer & Clark, 2001). Limited research explores how partners 
are involved in treatment decision making, whether partner involvement is congruent with 
the patient’s expectation, and whether partner involvement is related to satisfaction with the 
patient’s cancer treatment. Finally, little is known about the reasons for partner 
noninvolvement in treatment decision making.
To address these gaps, this exploratory study examined partners’ involvement in treatment 
decision making for patients with newly diagnosed localized prostate cancer. The 
researchers described partner preferences for and actual involvement in treatment decision 
making, congruence between partner involvement and patient preference, reasons for partner 
noninvolvement, and the relationship between partner involvement in treatment decision 
making and satisfaction with the patient’s treatment.
Methods
Participants
Partners were eligible if they (a) were aged 21 years or older, (b) were identified as the 
partner by a patient who was diagnosed with localized prostate cancer within the past three 
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months and consented to participate in the study, and (c) understood and spoke English. To 
keep the focus of this investigation on the patient’s cancer diagnosis and management, the 
researchers excluded partners if they had been diagnosed with cancer within the previous 
year or if they were receiving active treatment for cancer. All partners who met these criteria 
were included, regardless of their race, gender, or ethnicity.
Procedure
Institutional review board approval was obtained from the University of North Carolina at 
Chapel Hill. Participants were recruited through the North Carolina Prostate Cancer 
Comparative Effectiveness and Survivorship Study (NC ProCESS) (Chen et al., 2015). NC 
ProCESS aimed to examine the effectiveness of different treatment options using a 
prospective, population-based cohort of men with newly diagnosed localized prostate cancer 
enrolled throughout 100 counties in North Carolina using the Rapid Case Ascertainment of 
the North Carolina Central Cancer Registry.
NC ProCESS participants recruited during October 2011 and September 2012 were asked 
for permission to contact their partners regarding the study. After patient permission was 
received, a research assistant phoned the partner within two days to explain the details of the 
study and to screen for eligibility. For eligible partners who agreed to participate, a phone 
interview was scheduled within one week of the eligibility screening. The research assistants 
obtained informed consent by phone after mailing the written consent form to the partners 
and providing explicit explanation about the study to ensure the partner that the study 
materials were strictly confidential and would not affect patient care. Each interview was 
recorded and lasted about 30–60 minutes. To minimize the potential influence on treatment 
decision making, the phone interview was done after the patient made treatment decisions 
(i.e., within 1–3 months of treatment). Participants received a $30 gift certificate by mail 
when they completed the interview. The research assistants, who all had prior phone survey 
experience, received 64 hours of training about patient eligibility criteria, informed consent, 
and phone interview techniques. Weekly meetings were held, and interviews were randomly 
checked to ensure fidelity of the phone survey.
Measurement
Researcher-developed questionnaires were used in the phone survey. The questions 
regarding partner involvement in treatment decision making were developed based on a 
literature review and the opinions of urologic and radiation oncologists. These questions 
were categorized into five domains. The patient’s and his partner’s preference for and actual 
partner involvement in treatment decision making reported by partners included three items 
with dichotomized “yes” or “no” responses. Partner satisfaction with treatment included one 
five-point Likert-type item with responses ranging from “not at all” to “a lot.” In the current 
study, partner satisfaction with the treatment patients received was categorized into “very 
satisfied” (i.e., those who responded “a lot”) and “less than very satisfied” (including those 
whose responses were “not at all,” “a little,” “somewhat,” and “moderately satisfied”). 
Activities of partner involvement included six items with dichotomized “yes” or “no” 
responses (e.g., gathering information, visiting the doctor together). Reasons for partner 
noninvolvement in decision making each included seven five-point Likert-type items with 
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responses ranging from “not at all” to “a lot.” In the current study, the researchers 
dichotomized the responses into “yes” (i.e., presence of the reason, including “moderately” 
and “a lot”) and “no” (i.e., absence of the reason, including “not at all,” “a little,” and 
“somewhat”). Congruence of partner involvement in treatment decision making and patient 
preference was derived from tabulating the question asking about patient preference of 
partner involvement (“yes” if the patient preferred partner involvement and “no” if the 
patient preferred partner noninvolvement) and the question about partner evaluation of his or 
her actual involvement (“yes” if the partner was involved and “no” if the partner was not 
involved). Partner involvement in treatment decision making was considered congruent with 
patient preference if the partner’s responses to both questions were the same (i.e., patient 
preferred involvement and partner was involved or patient did not expect involvement and 
partner was not involved). The researchers considered partner involvement in treatment 
decision making discordant if the partner’s responses to these two questions were different 
(i.e., patient preferred involvement and partner was not involved or patient did not expect 
involvement and partner was involved). The researchers also obtained patient and partner 
demographic information (see Table 1).
Data Analysis
The researchers analyzed the data using SAS®, version 9.3. The researchers first assessed 
bivariate relationships between each of the characteristics of interest using chi-squared tests 
for categorical characteristics and t tests for continuous characteristics. The researchers used 
logistic regression to examine the potential relationship between activities of partner 
involvement in treatment (e.g., having conversations with the doctor) and partner satisfaction 
with patient treatment. After fitting the full model with all possible partner involvement 
activities, the researchers used backwards elimination to obtain a reduced model, 
sequentially eliminating any partner involvement activity that was not significant at the α = 
0.05 level. In the full and reduced models, the researchers controlled for the demographic 
variables of patient age and partner employment status because these variables were 
statistically associated with partner treatment satisfaction in bivariate analyses.
Results
Among 488 patients who received information about this project, 389 (80%) had partners 
and gave permission and contact information for the research staff to contact their partners. 
The researchers approached 316 partners (65%) successfully (contact information for 73 
partners [15%] was not current) and completed informed consent and questionnaires for 281 
partners (58%). The recruitment rate was 89%.
Overall, 228 partners (81%) reported involvement in treatment decision making, 205 (73%) 
reported being very satisfied with treatment the patients received, and 242 (86%) reported 
that their involvement in treatment decision making was congruent with patient preference.
Regarding the activities of partner involvement, partners most frequently worked as a team 
with the patient (n = 267, 95%), discussed treatment options with the patient (n = 247, 88%), 
went to doctor appointments with the patient (n = 244, 87%), were involved in conversations 
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with providers (n = 230, 82%), and gathered information for the patient (n = 191, 68%). 
Partners less frequently helped the patient get a second opinion (n = 67, 24%). Two hundred 
twenty-eight of the partners (81%) reported being involved in multiple activities related to 
patient care.
In bivariate analyses (see Table 2), among the partner and patient characteristics, patient age 
and partner employment were significantly associated with partners being very satisfied with 
treatment. Among the partner involvement activities, the following variables were associated 
with partner satisfaction with patient treatment: partner involvement congruence, partners 
who went to doctor visits with the patients for their cancer diagnosis, partners who were 
involved in the patients’ conversations with their doctor, and partners who discussed 
different treatment options with the patients.
In the full model of multivariate analysis that included all variables that were statistically 
significant in bivariate analyses (see Table 3), partner employment status was statistically 
significant (p < 0.05) and conversations with doctors were marginally significant (p = 0.07). 
In the reduced model, partner involvement in the patients’ conversations with their doctor 
were more likely to be associated with partner satisfaction with the patients’ treatment. 
Partners who were not working also had higher odds of being very satisfied with treatment.
Discussion
The current study systematically examined partner involvement in treatment decision 
making for men with localized prostate cancer and satisfaction with the treatment they 
received. The researchers’ findings supported that the majority of the partners engaged in 
different activities during treatment decision making; most partners reported that their 
involvement in treatment decision making was congruent with patient preference, and most 
partners who were involved in decision making were very satisfied with the patients’ 
treatment. The researchers’ identification of the reasons for partner noninvolvement in 
decision making and the factors that were related to partner satisfaction with the patients’ 
treatment (e.g., participating in conversations with the patient’s doctor) have implications for 
clinical practice and additional intervention research.
The researchers’ findings indicate that providers and researchers need to pay attention to the 
different relationship dynamics related to partner involvement when promoting shared 
decision making and family involvement. Couples’ relationship dynamics provide a 
contextual background against which treatment decisions are negotiated and made (Boehmer 
& Clark, 2001; Schumm, Skea, McKee, & N’Dow, 2010). In the current study, 25 partners 
(9%) were not involved in treatment decision making because the patients did not want them 
to be involved. This result indicates that researchers and clinicians need to be mindful of the 
potentially different preferences in partner involvement and provide preference-sensitive 
care accordingly. In addition, 213 participants (76%) had partner involvement congruent 
with patient preference, whereas 28 (10%) did not get involved although the patients wanted 
them to be involved, and 11 (4%) were involved although the patients did not want them to 
be involved. The researchers’ results indicate that, in addition to the differing perceptions of 
prostate cancer–related issues (e.g., quality of life, the impact of sexual functioning) between 
Symes et al. Page 5













patients and their partners (Rivers et al., 2011), some couples also are challenged by their 
incongruence in partner involvement. Involving partners in treatment decisions can be 
beneficial because of the negative impact of prostate cancer diagnosis and treatment on the 
well-being of the patient, his partner (Street et al., 2010; Venetis, Magsamen-Conrad, 
Checton, & Greene, 2014), and their relationship (Green, Wells, & Laakso, 2011; Wu et al., 
2013). Additional decision aid interventions may need to resolve this incongruence or tailor 
materials based on couples’ preferred type of decision-making involvement styles to achieve 
better treatment satisfaction.
Among partners who indicated that they were not involved (see Figure 1), one of the most 
frequently reported reasons was that the partner believed the treatment decision was an 
independent decision for the patient or his healthcare provider. In previous studies, about 
40% of the partners of men with localized prostate cancer preferred to take a passive role in 
treatment decision making (Davison et al., 2002) or wanted to avoid influencing the patient 
because they did not want to put additional pressure on him (Davison et al., 2002; Srirangam 
et al., 2003). In the current study, 94 partners (33%) who reported no involvement in 
treatment decision making had concerns with the negative effects a wrongly chosen decision 
may have on their relationship with the patient. Although the population was relatively 
small, the current study reminds researchers and clinicians of the dilemma that some 
partners may face when clinicians promote shared decision making for men with localized 
prostate cancer and their partner. Provider encouragement of the partner to ask questions 
during cancer-related clinic visits has been associated with more patient–partner interaction 
during the treatment decision-making process (Zeliadt et al., 2011). Additional research may 
need to target the common reasons for partner noninvolvement and ensure the positive 
effects of partner involvement to promote the benefits of shared decision making for patients 
and their partners.
The researchers found that partners who were involved in conversations with the patient’s 
doctor were more likely to be very satisfied with the patient’s treatment than when partners 
were not involved in the conversations. When partners directly communicate with the 
patients’ doctor, their questions and concerns about the different treatment options are 
addressed and their awareness of the outcomes of various treatments may be enhanced. 
Therefore, they can better understand the treatment their male partner receives and feel more 
confident in the treatment decision, which in turn may forestall potential distress and 
increase their satisfaction with the patient’s treatment.
Lastly, the researchers found an association between partners who were not working and 
partner satisfaction with treatment. Partners who were not working may have had more time 
to be involved in information-seeking activities that could lead to higher confidence levels 
and more satisfaction about the treatment decision. Intervention efforts may focus on 
providing working partners with the tools they need to become involved and more satisfied 
with the patient’s care.
The current study had key strengths, including the generalizability of the results compared to 
previous studies that used convenience samples. The participants in the current study were 
recruited throughout 100 counties in North Carolina using the Central Cancer Registry and 
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were diverse in their racial/ethnic backgrounds, socioeconomic status, rural/urban residence, 
and treatment location (community versus cancer hospitals). In addition, the researchers 
collected the data within three months after the patients made their treatment decision, 
which improves the recall and reliability of the reported results. Previous studies relied on 
information recalled months to years after the initial diagnosis and treatment (Feltwell & 
Rees, 2004; Hall, Boyd, Lippert, & Theodorescu, 2003; Sinfield et al., 2008; Srirangam et 
al., 2003; Street et al., 2010), which can be inaccurate and biased (Litwin & McGuigan, 
1999).
One limitation of the current study is that the assessment of partner satisfaction was only 
measured immediately after patients received their treatment. More research is needed to 
explore whether the findings hold in long-term follow-up. In addition, the researchers relied 
on literature and expert opinion to create the survey used to assess partner involvement in 
treatment decisions because a validated survey does not exist. Lastly, although the current 
study surveyed patients and partners throughout North Carolina and had a recruitment rate 
of 89%, it still has limitations in generalizability. The patients who denied their partners’ 
participation may have been self-selected, and the patients who permitted their partners to be 
contacted may have been more likely to involve their partners in treatment decision making 
than patients who declined to have their partners contacted. Additional studies should collect 
data of patients who decline to involve their partners in the study and compare 
characteristics of these patients with those who allow partner involvement. In addition, 
although 56 participants (20%) in the current study were African American, additional 
studies should oversample a higher percentage of African American men to increase 
generalizability because African American men have a disproportionately higher incidence 
of prostate cancer than non-Hispanic Caucasian men (American Cancer Society, 2015; 
National Cancer Institute, 2014).
Implications for Nursing
The findings from the current study have several implications for nurses because they play 
an important role in helping men and their partners make prostate cancer treatment decisions 
(Davison, Oliffe, Pickles, & Mroz, 2009; Maliski, Clerkin, & Litwin, 2004). Nurses—
including nurse case managers—often assess patient preferences for treatment decision 
making and, in turn, can relay these preferences to other care providers such as urologists 
(Maliski et al., 2004). Nurses must be aware that many patients and their partners want 
partner involvement in treatment decision making and that involving partners in discussions 
about treatment decisions, if both parties prefer this type of involvement, may lead to better 
patient and partner satisfaction with treatment.
Conclusion
The current study contributes to the literature in several ways. The findings highlight how 
partners are involved in the treatment decision-making process for men with newly 
diagnosed localized prostate cancer and how this involvement relates to partner satisfaction 
with the treatment received. The current study also illuminates the level of congruence 
between patient preference for partner involvement and actual partner involvement, as well 
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as why some partners choose not to be involved in treatment decision making. Partners of 
men with prostate cancer represent a group of individuals who have been understudied, and 
the current study provides clues as to how to harness decision making in prostate cancer care 
that best meets the variable needs of patients and their partners.
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Most partners of patients with prostate cancer were involved with treatment decision 
making and were satisfied with the patient’s treatment.
The amount of partner involvement in decision making was mostly congruent with 
patient preferences.
Partners who were involved with the patient’s conversation with the doctor were 
more satisfied with the patient’s treatment than partners who were not involved in 
patient–doctor conversations.
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Reasons for Noninvolvement Among Partners Who Indicated Noninvolvement in Patients’ 
Treatment Decision Making (N = 53)
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Table 1






Median Range Median Range
Age (years) 62 35–79 65 42–81
Time partnered (years) 35 1–63 – –
Characteristic n % n %
Race
 Caucasian 230 82 224 80
 African American or other   51 18   56 20
 Missing data – –     1 –
Education
 High school graduate or lower   83 30   83 30
 Some college or higher 197 70 198 70
 Missing data     1 – – –
Employment
 Not working 180 64 158 56
 Presently working 101 36 123 44
Household income ($)
 Less than 40,000   81 29 – –
 40,001–70,000   78 28 – –
 More than 70,000 112 40 – –
 Unsure   10   4 – –
Satisfaction with care
 Very satisfied 205 73 – –
 Less than very satisfied   76 27
Partner involvement congruence
 Patient preferred involvement and partner was involved. 216 77 – –
 Patient preferred involvement and partner was not involved.   29 10 – –
 Patient did not prefer involvement and partner was involved.   12   4 – –
 Patient did not prefer involvement and partner was not involved.   24   9 – –
Note. Because of rounding, percentages may not total 100.
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